Sign In
Buy BSEM
$4.14
-0.0290 (-0.696%)
At Close: Jun 03, 2026
BioStem Technologies Announces Filing of 2021 First Quarter Financial Reports
11:34am, Monday, 24'th May 2021
Pompano Beach, Fl., May 24, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allograf
BioStem Technologies, Inc. Announces Launch of National Sales Force Expansion
09:00am, Thursday, 15'th Apr 2021
Pompano Beach, Fl., April 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing elemen
BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE™
09:00am, Thursday, 25'th Mar 2021
Pompano Beach, Fl., March 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing elemen
BioStem Technologies, Announces Filing of 2020 Quarterly Reports
02:00pm, Thursday, 24'th Dec 2020
Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allograf
